Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Issues And Trends In Healthcare Delivery System

Issues And Trends In Healthcare Delivery System

The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...

Drug Products: Biologics, Biosimilars and Interchangeables

Drug Products: Biologics, Biosimilars and Interchangeables

Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...

Ethical Issues

Ethical Issues

Nurses are essential in patient care, upholding the ethical principles of their profession and effectively navigating ethical dilemmas. Neglecting ethical issues can lead to inadequate patient care, compromised therapeutic relationships, and moral distress among healthcare workers.
Ethical Concerns in Healthcare:

Clinical Trials: Overview

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...

Drug Regulation

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...

Pharmacovigilance

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A multi model ensemble reveals net climate benefits from regenerative practices in US Midwest croplands.

Scientific reports·2025

Same author

Biology-inspired engineering for circular bioeconomy systems.

Journal of biological engineering·2025

Same author

Correction: A time-course comparative clinical and immune response evaluation study between the human pathogenic Orientia tsutsugamushi strains: Karp and Gilliam in a rhesus macaque (Macaca mulatta) model.

PLoS neglected tropical diseases·2023

Same author

A time-course comparative clinical and immune response evaluation study between the human pathogenic Orientia tsutsugamushi strains: Karp and Gilliam in a rhesus macaque (Macaca mulatta) model.

PLoS neglected tropical diseases·2022

Same author

Dynamic QTL-based ecophysiological models to predict phenotype from genotype and environment data.

BMC plant biology·2022

Same author

Nationwide Seroprevalence of Scrub Typhus, Typhus, and Spotted Fever in Young Thai Men.

The American journal of tropical medicine and hygiene·2022

Search research articles

Related Experiment Video

Updated: May 22, 2026

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

When is medical industry backing lacking?

James W Jones¹, Laurence B McCullough

¹The Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston, TX, USA. jwjones@bcm.tmc.edu

Journal of Vascular Surgery

|May 22, 2012

Summary

This summary is machine-generated.

Dr. Krasia faces an ethical dilemma regarding a pharmaceutical company's offer. The offer involves financial support and training center status in exchange for participation in a comparative study, potentially influencing clinical decisions.

More Related Videos

Experimental Approaches to Tissue Engineering

Experimental Approaches to Tissue Engineering

Published on: August 30, 2007

Related Experiment Videos

Last Updated: May 22, 2026

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

Experimental Approaches to Tissue Engineering

Experimental Approaches to Tissue Engineering

Published on: August 30, 2007

Area of Science:

Medical Ethics
Pharmaceutical Industry Practices
Clinical Trial Design

Background:

A sales representative from Megastint proposed financial support for educational conferences and establishing an institution as a training center.
This offer is contingent upon Dr. Krasia's participation in a new study comparing an existing product with a newly approved, more expensive alternative.
Dr. Krasia's department currently utilizes Megastint products, and he chairs the utilization committee responsible for approving new, costly medical items.

Discussion:

The offer presents a potential conflict of interest, as financial incentives may influence the selection of pharmaceuticals or devices.
Dr. Krasia must navigate the ethical implications of accepting support that could bias his professional judgment and committee decisions.
The situation highlights the need for transparency and robust conflict-of-interest policies in clinical practice and research.

Key Insights:

Accepting the offer could compromise the integrity of the utilization committee's decision-making process.
Dr. Krasia's primary responsibility is to his patients and the institution, prioritizing evidence-based choices over financial inducements.
Maintaining objectivity is crucial when evaluating new medical products, especially when financial ties exist.

Outlook:

Dr. Krasia should decline the offer to avoid any perception of impropriety and uphold ethical standards.
He should report the offer to relevant institutional ethics boards or compliance officers.
Future interactions with pharmaceutical companies should be managed with strict adherence to institutional policies on conflicts of interest.